X-153418700-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001386943.1(ZFP92):c.-66G>A variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000232 in 1,165,826 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001386943.1 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZFP92 | NM_001136273.2 | c.61G>A | p.Val21Met | missense_variant | 4/6 | ENST00000338647.7 | NP_001129745.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZFP92 | ENST00000338647.7 | c.61G>A | p.Val21Met | missense_variant | 4/6 | 5 | NM_001136273.2 | ENSP00000462054.1 |
Frequencies
GnomAD3 genomes AF: 0.00000897 AC: 1AN: 111511Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 33715
GnomAD3 exomes AF: 0.0000345 AC: 4AN: 115992Hom.: 0 AF XY: 0.0000241 AC XY: 1AN XY: 41438
GnomAD4 exome AF: 0.0000247 AC: 26AN: 1054315Hom.: 0 Cov.: 31 AF XY: 0.0000290 AC XY: 10AN XY: 344905
GnomAD4 genome AF: 0.00000897 AC: 1AN: 111511Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 33715
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2022 | The c.61G>A (p.V21M) alteration is located in exon 2 (coding exon 2) of the ZFP92 gene. This alteration results from a G to A substitution at nucleotide position 61, causing the valine (V) at amino acid position 21 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at